The National Agency For Food And Drug Administration And Control (NAFDAC) has announced the withdrawal, suspension, and cancellation of 101 pharmaceutical products across Nigeria.
According to the agency, the affected medicines and related products are no longer authorised for manufacture, importation, exportation, distribution, advertisement, sale, or use in the country.
The delisted products include Artemether/Lumefantrine 40mg/240mg Tablets, Amaryl M SR Tablets, Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg, Aprovasc 150mg/5mg Tablets, ASAQ (Artesunate Amodiaquine Winthrop) 100mg/270mg Tablets, Betopic Eye Drop, Efavirenz 600mg Tablets, and Flagyl Suspension.
Advertisement
READ MORE : Nigeria Not Hard To Govern If Leaders Are Honest – Obasanjo
Other affected items are Iliadin Adult 0.05% Metered Nose Spray, Invanz 1g Injections, and Invega (Paliperidone) 3mg Extended Release Tablets.
In a statement shared via its official X handle, NAFDAC explained the categories of the regulatory actions taken.
“A product’s Certificate of Registration is considered withdrawn when its use is discontinued at the request of the Market Authorisation Holder.
“A registration certificate may be suspended when the conditions under which it was issued are no longer met, pending a determination by the agency.
“It is regarded as cancelled when NAFDAC revokes the registration license entirely,” the agency stated.
NAFDAC urged the public, as well as stakeholders in the pharmaceutical and food industries, to take note of the new directive and ensure strict compliance.
This latest action underscores the agency’s ongoing efforts to safeguard public health and maintain the quality, safety, and efficacy of medicines and other regulated products in Nigeria.
